BioSerenity
Signal active
Investment Firm
Overview
BioSerenity souhaite aider la communauté scientifique à mieux comprendre l'épilepsie pour mieux la soigner. Une fois anonymisées et privées de tout lien avec le patient, les données recueillies seront mise à disposition des chercheurs de l'Institut du Cerveau et de la Moelle épinière (ICM). C'est un pas décisif pour faire avancer la recherche sur l'épilepsie et améliorer le futur du diagnostic
Highlights
Founded
2014
Industry
Software
Employees
251-500
Investment
1
Lead Investment
0
Exits
undefined
Stages
N/A
Investor Type
N/A
Location
Europe
Contact Information
Social
Profile Resume
BioSerenity, established in 2014 and headquartered in Europe., specializes in investments across Health Care, Medical Device, Health Diagnostics, Social Entrepreneurship, Government, Office Administration, Financial Services, Analytics, Sensor, Machinery Manufacturing. Their recent investments include BOYDSenseBOYDSense SAS, European Innovation Council, Jolt Capital, Alpha MOS. The highest investment round they participated in was $303.6M. Among their most notable exits are BOYDSenseBOYDSense SAS and European Innovation Council. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
BioSerenity has made 1 investments. Their most recent investment was on Apr 05, 2024, when BOYDSenseBOYDSense SAS raised $7.6M.
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 05, 2024 | BOYDSenseBOYDSense SAS | Health Care | 7.6M |
Exits
0
Funding Timeline
Funding rounds
1
Investors
9
Funds
0
Funding Rounds
1
BioSerenity has raised 1 rounds. Their latest funding was raised on Apr 05, 2024 from a Venture Round - BOYDSenseBOYDSense SAS round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 05, 2024 | Venture Round - BOYDSenseBOYDSense SAS | - | 7.6M | - |
Investors
14
BioSerenity is funded by 14 investor(s). Jolt Capital and Idinvest Partners Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Idinvest Partners | No | Series B - BioSerenity | 73.0M |
| - | Yes | Corporate Round - BioSerenity | 0 |
| - | Yes | Corporate Round - BioSerenity | 0 |
Jolt Capital | Yes | Venture Round - BioSerenity | 25.7M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.